FDA — authorised 26 October 1984
- Application: NDA050557
- Marketing authorisation holder: VALEANT INTL
- Local brand name: BENZAMYCIN
- Indication: GEL — TOPICAL
- Status: approved
FDA authorised Benzamycin on 26 October 1984
Yes. FDA authorised it on 26 October 1984.
VALEANT INTL holds the US marketing authorisation.